Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide for weight management — sold in the UK as Wegovy — is a once-weekly injection, so the time of day matters less than you might think. What genuinely counts is picking a consistent day and roughly the same time each week, and sticking to it. That said, most people find that choosing a time they can actually remember (and that sits alongside their routine) makes the whole thing easier to keep up. Semaglutide is a prescription-only medicine; a prescriber confirms your specific schedule.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
For the injection form, no, not in any clinically meaningful way. Semaglutide has a half-life of roughly one week, which means its concentration in your blood builds gradually and stays relatively stable between doses. There is no narrow window to hit. The NHS patient information for semaglutide confirms it can be taken at any time of day, with or without a meal. Morning, lunchtime, evening, whichever you will actually do without forgetting.
The one genuinely important thing is picking a day and time and keeping it. Some people tie it to something fixed: a Sunday morning before breakfast, or a Thursday after putting the bins out. That kind of anchor beats any abstract advice about "optimal timing".
Nausea tends to be worst in the first few weeks after starting or after a dose increase. Some people find injecting in the evening means any unsettled feeling passes overnight; others prefer mornings so they feel more in control during the day. Neither is medically superior, it is personal preference. If you want to think through which time of day works best for weight loss specifically, we have covered the evidence there.
Yes, and this is where timing becomes genuinely strict. The oral Wegovy tablet (approved by the MHRA on 11 June 2026 as the first oral GLP-1 medicine licensed for weight management in the UK) uses an absorption enhancer called SNAC to get semaglutide across the gut lining. That process only works reliably under very specific conditions.
The tablet must be taken first thing in the morning, on a completely empty stomach, with a small amount of plain water (up to around 120ml). You then wait at least 30 minutes before eating, drinking anything else (including coffee or tea), or taking other oral medicines. Swallow it whole, do not crush or chew it.
A common misconception is that this rule is just a general guideline, like "try to take it before breakfast". It is not. Food, drink and other medicines in the stomach at the time of dosing can significantly reduce absorption, potentially meaning less of the medicine gets into your system. The 30-minute window is built into the licensed dosing schedule. The upside is that no refrigeration is needed, the tablet is room-temperature stable, making it far more travel-friendly than the injection. You can read more on the Wegovy treatment page.
A degree of flexibility is built in. The licensed guidance allows you to change your injection day as long as your last dose was at least four days ago. So if you normally inject on Mondays but want to shift to Thursdays, you can, provided you have maintained that minimum gap.
What you want to avoid is letting the gap shrink to less than four days, because doubling up the effective dose by accident raises the risk of nausea, vomiting and other gastrointestinal effects. For the first few days on a new dose, those side effects can already feel pronounced, day one on semaglutide and day two are often the most unsettled. Compressing the schedule makes that harder.
If you miss a dose entirely, the Patient Information Leaflet guidance applies: take it as soon as you remember, provided your next scheduled dose is more than two days away. If fewer than two days remain, leave it and resume your normal schedule. Do not take two doses to catch up. Questions about your specific situation (especially if you are changing doses or switching from another medicine) are best directed to your prescriber.
Most people stabilise into a routine within the first month. The early weeks are when timing tweaks matter most, because that is when side effects are most likely and when the habit is still forming. Once you are on your maintenance dose and the routine is set, semaglutide tends to fade into the background, a weekly habit rather than a daily one.
How quickly the medicine itself starts working is a separate question from timing. How long semaglutide takes to work depends on your starting dose, how your body responds, and whether the titration schedule is followed, not on which hour of the day you inject. The NHS England guidance on weight management injections covers what patients should expect from treatment as a whole, including the wrap-around lifestyle support that sits alongside the medicine.
If you are weighing up whether semaglutide is the right option for you, or want to know more about how treatment is assessed, the semaglutide overview is a good place to start. When you are ready to take the next step, our prescribers are available seven days a week, you can check your eligibility with a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.